Posted on 3/6/19
Axsome Therapeutics Secures $24 Million Growth Capital Loan Facility Led by Silicon Valley Bank
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system
Posted on 3/6/19
FDA OKs J&J's Esketamine Nasal Spray For Depression
As expected, the FDA approves Johnson & Johnson (NYSE:JNJ) unit Janssen Pharmaceutical's SPRAVATO (esketamine) CIII nasal spray, together with an oral antidepressant, for adults with treatment-resistant . . .
Posted on 3/6/19
If The Celgene Deal Fails, Who Would Buy Bristol-Myers Squibb?
Summary BMY is planning to acquire CELG, but critics have emerged, often saying that BMY should sell itself. However, it is not clear to me that . . .
Posted on 3/5/19
Venice Family Clinic Honors Ivy Kagan Bierman And Russel Tyner At The Annual Silver Circle Gala
Venice Family Clinic hosts its 37th annual Silver Circle Galaon Monday, March 25 at the Beverly Wilshire Hotel where Ivy Kagan Bierman will be receiving the . . .
Posted on 3/5/19
The Ash Center Introduces “Hair On Fifth” A New Approach To Healthy Hair
The Ash Center, a comprehensive wellness center dedicated to longevity and anti-aging, announces “Hair on Fifth” a new approach to the prevention and solution of hair . . .
Posted on 3/5/19
SCWorx Signs New Agreement with a University Medical Center For $649,000
NEW YORK--(BUSINESS WIRE)--SCWorx Corp (NASDAQ: WORX) today announced the signing of a new agreement with a 448 bed New York-based single standing university medical center. The . . .
Posted on 3/5/19
Merck Begins Tender Offer to Acquire Immune Design
Merck (NYSE: MRK), known as MSD outside the United States and Canada, is commencing today, through a subsidiary
Posted on 3/5/19
Can This Biotech Puppy Run With the Big Dogs?
If you've never heard of Eidos Therapeutics (NASDAQ:EIDX) during its eight-month history as a public company, try not to beat yourself up about it. On an . . .
Posted on 3/5/19
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting . . .
Posted on 3/4/19
IBM Watson Health Announces 100 Top Hospitals
IBM Watson Health (NYSE: IBM) today published its 100 Top Hospitals annual study identifying top–performing hospitals in the U.S. This study spotlights the best–performing hospitals in . . .
Posted on 3/4/19
Henry Schein Completes Acquisition Of North American Rescue
Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners
Posted on 3/4/19
ContraFect Announces $6.94M In Funding From CARB-X
ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics
Posted on 3/4/19
Johnson & Johnson (JNJ) Management on 8th Annual SVB Leerink Global Healthcare Conference - Transcript
Johnson & Johnson (NYSE:JNJ) 8th Annual SVB Leerink Global Healthcare Conference February 28, 2019 11:00 AM ETCompany ParticipantsChris DelOrefice – Vice President of Investor RelationsAshley McEvoy . . .
Posted on 3/4/19
Better Buy: Intuitive Surgical vs. Johnson & Johnson
Intuitive Surgical (NASDAQ:ISRG) is best known for its da Vinci robotic surgical system. Johnson & Johnson (NYSE:JNJ) might be most famous for its consumer healthcare products. . . .
Posted on 3/4/19
Better Buy: Sirius XM vs. Netflix
Sirius XM Holdings (NASDAQ:SIRI) and Netflix (NASDAQ:NFLX) dominate their respective corners of the entertainment industry. As they've risen to power over the last decade, they've earned . . .
Posted on 3/4/19
Lupus Therapeutics Partners with Takeda on Phase 1 Trial
The Lupus Research Alliance and its affiliate, Lupus Therapeutics announced a collaboration with Takeda Pharmaceutical Company Limited, to evaluate the investigational biologic TAK-079 as a potential . . .
Posted on 3/4/19
Synergy Pharmaceuticals Receives Court Approval for the Sale of Its Assets to Bausch Health
Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today confirmed that the previously announced agreement . . .
Posted on 3/4/19
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on February 25, 2019 it approved non-statutory stock options to purchase an aggregate of 125,000 shares of its . . .
Posted on 3/3/19
Tonix Pharmaceuticals Announces Share Repurchase Program
NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) today announced that its Board of Directors has . . .
Posted on 3/3/19
TG Therapeutics Announces Approximately $85 million in Equity and Debt Financings
NEW YORK, March 01, 2019 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical company developing medicines for patients with B-cell mediated diseases, today announced . . .
Posted on 3/1/19
Why Celgene Stock Dropped 9% Today
What happenedShares of cancer-treating biopharmaceutical company Celgene (NASDAQ:CELG) sold off on Thursday, closing down 8.6% after yet another high-profile shareholder of Bristol-Myers Squibb (NYSE:BMY) -- the . . .
Posted on 3/1/19
Valeritas Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
BRIDGEWATER, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a . . .
Posted on 2/28/19
Antares Pharma Reports Fourth Quarter and Full Year 2018 Operating and Financial Results
EWING, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today reported unaudited consolidated financial results and operational highlights for the fourth quarter . . .
Posted on 2/28/19
Amicus Therapeutics Announces Full-Year 2018 Financial Results and 2019 Corporate Updates
CRANBURY, N.J., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on discovering, developing and delivering novel medicines for rare . . .
Posted on 2/28/19
Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Results
WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Eagle Pharmaceuticals, Inc. (Nasdaq:EGRX) today announced its financial results for the three months and full year ended December 31, 2018. Highlights of, and . . .

